An All-in-One Attack: Microneedle-Delivered Bio-Hybrid Nanoagonist for Tumor Immunotherapy
ACS Applied Bio Materials · 18.05.2026 · 9 (10) · 4547-4565
DOI: 10.1021/acsabm.6c00180 ↗Kurz gefasst
Fachartikel in der Zeitschrift ACS Applied Bio Materials, online erschienen am 27.04.2026. Verfasst von Ang Li und 5 weiteren Autor:innen. Beteiligte Einrichtung: Xuzhou Clinical College, Xuzhou Medical University, Xuzhou, Jiangsu 221009, P. R. China. Hauptthemen laut MEDLINE: Immunotherapy, Biocompatible Materials, Antineoplastic Agents, Mouth Neoplasms. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 37 Literaturangaben. Gefördert von: Xuzhou Municipal Science and Technology Bureau, Jiangsu Commission of Health, Xuzhou City.
Abstract (Originalsprache)
Kein Abstract verfügbar.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Xuzhou Clinical College, Xuzhou Medical University, Xuzhou, Jiangsu 221009, P. R. China.
- Department of Stomatology, Xuzhou Central Hospital, Xuzhou, Jiangsu 221009, P. R. China.
ORCID-Profile: Ang Li
Förderung
- Xuzhou Municipal Science and Technology Bureau
- Jiangsu Commission of Health
- Xuzhou City
Zitieren
APA
Li, A., Shan, X. L., Zhu, S. H., Liu, Z., Guo, S. Q., & Meng, J. (2026). An All-in-One Attack: Microneedle-Delivered Bio-Hybrid Nanoagonist for Tumor Immunotherapy. ACS Applied Bio Materials, 9(10), 4547-4565. https://doi.org/10.1021/acsabm.6c00180
Vancouver
Li A, Shan XL, Zhu SH, Liu Z, Guo SQ, Meng J. An All-in-One Attack: Microneedle-Delivered Bio-Hybrid Nanoagonist for Tumor Immunotherapy. ACS Applied Bio Materials. 2026;9(10):4547-4565. doi:10.1021/acsabm.6c00180
BibTeX
@article{Li2026,
author = {Li, Ang and Shan, Xue Long and Zhu, Sheng Hui and Liu, Zheng and Guo, Shu Qi and Meng, Jian},
title = {An All-in-One Attack: Microneedle-Delivered Bio-Hybrid Nanoagonist for Tumor Immunotherapy},
journal = {ACS Applied Bio Materials},
year = {2026},
volume = {9},
number = {10},
pages = {4547--4565},
doi = {10.1021/acsabm.6c00180}
}
EUVIMED